Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lexeo Therapeutics, Inc.

LXEO Clue Score11
United States Fiscal year ends December CIK 0001907108 Results filed 12 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Richard Nolan Townsend
6 Apr 2026
Chief Executive Officer
Sold on a plan
55,000
$5.69
$313.14K

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 482,573
History held since 9 Nov 2023